Company / Gross Profit per Share
GYRE THERAPEUTICS, INC. Gross Profit per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.33
FY2024
5-year range
$1.29 / $1.53
FY2022-FY2024
Trend
-13.3%
vs FY2023
Sector context
#24 of 29
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s gross profit per share of $1.33 is lower than 83% of companies in the Health Care sector (FY2024). Improved from $1.29 to $1.33 over the past 2 years.
Based on SEC 10-K filings.
1.33 in FY2024.
Improved from $1.29 to $1.33 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 29This company $1.33 Sector average $8.11
▼
-83.6% below sector average
Key checks
Key Insights
- In FY2024, gross profit per share decreased 13.3% year-over-year.
- Ranks #24 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.33 | -13.3% |
| FY2023 | $1.53 | +19.0% |
| FY2022 | $1.29 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026